| # | Drug | Count |
|---|---|---|
| 0 | RIBOCICLIB | 4 |
| 1 | CARBOPLATIN | 2 |
| 2 | LETROZOLE | 2 |
| 3 | PACLITAXEL | 2 |
| 4 | PACLITAXEL (AIBUMIN-BOUND) | 2 |
| 5 | PEMBROLIZUMAB | 2 |
| 6 | BIOTIN | 1 |
| 7 | CAPECITABINE | 1 |
| 8 | CISPLATIN | 1 |
| 9 | CLOZAPINE | 1 |
| # | Drug | Count | Frequency |
|---|---|---|---|
| 0 | PERTUZUMAB, TRASTUZUMAB, AND HYALURONIDASE-ZZXF | 1 | 0.0002 |
| 1 | TUCATINIB | 1 | 0.0001 |
| 2 | RIBOCICLIB | 4 | 0.0001 |
| 3 | GEFITINIB | 1 | 0.0001 |
| 4 | FAM-TRASTUZUMAB DERUXTECAN-NXKI | 1 | 0.0001 |
| 5 | GOSERELIN | 1 | 0.0001 |
| 6 | DURVALUMAB | 1 | 0.0000 |
| 7 | ENALAPRIL MALEATE | 1 | 0.0000 |
| 8 | ERGOCALCIFEROL | 1 | 0.0000 |
| 9 | LETROZOLE | 2 | 0.0000 |
| # | Drug class | Count | Frequency |
|---|---|---|---|
| 0 | Endoglycosidase [EPC] | 1 | 0.0005 |
| 1 | Programmed Death Ligand-1 Blocker [EPC] | 1 | 0.0000 |
| 2 | Provitamin D2 Compound [EPC] | 1 | 0.0000 |
| 3 | Estrogen Receptor Antagonist [EPC] | 1 | 0.0000 |
| 4 | Programmed Death Receptor-1 Blocking Antibody [EPC] | 2 | 0.0000 |
| 5 | Microtubule Inhibitor [EPC] | 3 | 0.0000 |
| 6 | Aromatase Inhibitor [EPC] | 2 | 0.0000 |
| 7 | HER2/neu Receptor Antagonist [EPC] | 1 | 0.0000 |
| 8 | Arteriolar Vasodilator [EPC] | 1 | 0.0000 |
| 9 | Platinum-based Drug [EPC] | 3 | 0.0000 |